Research > Cancer

Oncological pathology

Number of publications
562
Publications search

  • Sanegre S; Eritja N; de Andrea C; Diaz-Martin J; Diaz-Lagares Á; Jácome MA; Salguero-Aranda C; García Ros D; Davidson B; Lopez R; Melero I; Navarro S; Ramon Y Cajal S; de Alava E; Matias-Guiu X; Noguera R

    Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma.

    Frontiers In Cell And Developmental Biology 9 670185-670185. .

    [doi:10.3389/fcell.2021.670185]

  • Buza N; Euscher ED; Matias-Guiu X; McHenry A; Oliva E; Ordulu Z; Parra-Herran C; Rottmann D; Turner BM; Wong S; Hui P

    Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study.

    Modern Pathology 34 1194-1202. .

    [doi:10.1038/s41379-021-00746-5]

  • Gil-Moreno A; Alonso-Alconada L; Díaz-Feijoo B; Domingo S; Vilar A; Hernández A; Gilabert J; Llueca A; Torné A; de Santiago J; Carbonell-Socias M; Lago V; Arias E; Sampayo V; Siegrist J; Chipirliu A; Sánchez-Iglesias JL; Pérez-Benavente A; Padilla-Iserte P; Santacana M; Matias-Guiu X; Abal M; Lopez-Lopez R

    M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patients.

    GYNECOLOGIC ONCOLOGY 161 681-686. .

    [doi:10.1016/j.ygyno.2021.03.022]

  • Concin N; Matias-Guiu X; Creutzberg CL; ESGO-ESTRO-ESP Endometrial Carcinoma Guideline Working Group

    Response to: Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 31 947-947. .

    [doi:10.1136/ijgc-2021-002668]

  • Devis-Jauregui L; Eritja N; Davis ML; Matias-Guiu X; Llobet-Navàs D

    Autophagy in the physiological endometrium and cancer.

    Autophagy 17 1-19. .

    [doi:10.1080/15548627.2020.1752548]

  • Velasco A; Tokat F; Bonde J; Trim N; Bauer E; Meeney A; de Leng W; Chong G; Dalstein V; Kis LL; Lorentzen JA; Tomic S; Thwaites K; Putzová M; Birnbaum A; Qazi R; Primmer V; Dockhorn-Dworniczak B; Hernández-Losa J; Soares FA; Gertler AA; Kalman M; Wong C; Carraro DM; Sousa AC; Reis RM; Fox SB; Fassan M; Brevet M; Merkelbach-Bruse S; Colling R; Soilleux E; Teo RYW; D'Haene N; Nolet S; Ristimäki A; Väisänen T; Chapusot C; Soruri A; Unger T; Wecgowiec J; Biscuola M; Frattini M; Long A; Campregher PV; Matias-Guiu X

    Multi-center real-world comparison of the fully automated Idylla™ microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer.

    VIRCHOWS ARCHIV 478 851-863. .

    [doi:10.1007/s00428-020-02962-x]

  • Moukarzel LA; Da Cruz Paula A; Ferrando L; Hoang T; Sebastiao APM; Pareja F; Park KJ; Jungbluth AA; Capella G; Pineda M; Levin JD; Abu-Rustum NR; Ellenson LH; Bel AV; Reis-Filho JS; Matias-Guiu X; Cadoo K; Stadler ZK; Weigelt B

    Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes.

    Modern Pathology 34 994-1007. .

    [doi:10.1038/s41379-020-00721-6]

  • Vieites, B; Lopez-Garcia, MA; Martin-Salvago, MD; Ramirez-Tortosa, CL; Rezola, R; de Salas, MS; Vilaro, LL; Villellas, FV; Burgues, O; Fernandez-Rodriguez, B; Galan, LA; Peg, V

    Patient follow-up of NEOVATTL study

    ANNALS OF ONCOLOGY 32 49-49. .

    [doi:10.1016/j.annonc.2021.03.079]

  • Cudos, AG; Murillo, SM; Subirats, OP; Galindo, AR; Rodriguez, JV; Guzman, DRS; Villellas, FV; Morales, CC; Olive, JM; Martinez, EI

    Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67

    BREAST 56 52-53. .

  • Mendaza, S; Fernandez-Irigoyen, J; Santamaria, E; Arozarena, I; Guerrero-Setas, D; Zudaire, T; Guarch, R; Vidal, A; Salas, JS; Matias-Guiu, X; Ausin, K; Gil, C; Hernandez-Alcoceba, R; Martin-Sanchez, E

    Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix

    Cancers 13 -. .

    [doi:10.3390/cancers13071739]

  • Archilla, I; Diaz-Mercedes, S; Aguirre, JJ; Tarragona, J; Machado, I; Rodrigo, MT; Lopez-Prades, S; Gorostiaga, I; Landolfi, S; Alen, BO; Balaguer, F; Castells, A; Camps, J; Cuatrecasas, M

    Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?

    Clinical and Translational Gastroenterology 12 -. .

    [doi:10.14309/ctg.0000000000000303]

  • Jan van Weelden W; Reijnen C; Küsters-Vandevelde HVN; Bulten J; Bult P; Leung S; Visser NCM; Santacana M; Bronsert P; Hirschfeld M; Colas E; Gil-Moreno A; Reques A; Mancebo G; Huvila J; Koskas M; Weinberger V; Bednarikova M; Hausnerova J; Snijders MPLM; Matias-Guiu X; Amant F; Krakstad C; van de Vijver K; McAlpine J; Pijnenborg J; ENITEC-consortium

    The cut-off for estrogen and progesterone receptor in endometrial cancer revisited: an ENITEC collaboration study.

    HUMAN PATHOLOGY 109 80-91. .

    [doi:10.1016/j.humpath.2020.12.003]